Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

By: Joyti Bajpai, MD Date: 12/07/2023 In a forthcoming interview, Jyoti Bajpai, MD, a renowned…

Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…

In an ongoing Phase 1/2 study, Constantine Tam, MD, a researcher and Professor of Haematology,…

In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

By. Robert Rifkin, MDDate: 12/13/2023 Robert Rifkin, MD, a medical oncologist and hematologist at SCRI…

In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…